|
Name |
(1S,3S,4R,6E,7S,8S,10R,11R,13Z,14R)-3,10-dihydroxy-6,13-bis[(2E,4E)-1-hydroxyhexa-2,4-dienylidene]-1,4,8,11-tetramethyl-2,9-dioxapentacyclo[8.4.0.03,8.04,14.07,11]tetradecane-5,12-dione
|
Molecular Formula | C28H32O8 | |
IUPAC Name* |
(1S,3S,4R,6E,7S,8S,10R,11R,13Z,14R)-3,10-dihydroxy-6,13-bis[(2E,4E)-1-hydroxyhexa-2,4-dienylidene]-1,4,8,11-tetramethyl-2,9-dioxapentacyclo[8.4.0.03,8.04,14.07,11]tetradecane-5,12-dione
|
|
SMILES |
C/C=C/C=C/C(=C\1/[C@H]2[C@@]3(C(=O)/C(=C(/C=C/C=C/C)\O)/[C@@H]4[C@](C1=O)([C@]5([C@]2(O[C@]3([C@]4(O5)C)O)C)O)C)C)/O
|
|
InChI |
InChI=1S/C28H32O8/c1-7-9-11-13-15(29)17-19-23(3)22(32)18(16(30)14-12-10-8-2)20-24(4,21(17)31)28(34)25(19,5)35-27(23,33)26(20,6)36-28/h7-14,19-20,29-30,33-34H,1-6H3/b9-7+,10-8+,13-11+,14-12+,17-15-,18-16+/t19-,20+,23-,24-,25+,26+,27+,28-/m1/s1
|
|
InChIKey |
OFOUJHGWJJEVMF-JIHTYFLJSA-N
|
|
Synonyms |
Trichodimerol; DTXSID201045457; 145174-90-9
|
|
CAS | 145174-90-9 | |
PubChem CID | 165365633 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 496.5 | ALogp: | 2.5 |
HBD: | 4 | HBA: | 8 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 134.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 36 | QED Weighted: | 0.261 |
Caco-2 Permeability: | -5.393 | MDCK Permeability: | 0.00004710 |
Pgp-inhibitor: | 0.993 | Pgp-substrate: | 0.171 |
Human Intestinal Absorption (HIA): | 0.035 | 20% Bioavailability (F20%): | 0.001 |
30% Bioavailability (F30%): | 0.097 |
Blood-Brain-Barrier Penetration (BBB): | 0.957 | Plasma Protein Binding (PPB): | 79.18% |
Volume Distribution (VD): | 1.956 | Fu: | 9.63% |
CYP1A2-inhibitor: | 0.005 | CYP1A2-substrate: | 0.974 |
CYP2C19-inhibitor: | 0.018 | CYP2C19-substrate: | 0.781 |
CYP2C9-inhibitor: | 0.032 | CYP2C9-substrate: | 0.002 |
CYP2D6-inhibitor: | 0 | CYP2D6-substrate: | 0.063 |
CYP3A4-inhibitor: | 0.351 | CYP3A4-substrate: | 0.939 |
Clearance (CL): | 6.998 | Half-life (T1/2): | 0.058 |
hERG Blockers: | 0.005 | Human Hepatotoxicity (H-HT): | 0.441 |
Drug-inuced Liver Injury (DILI): | 0.763 | AMES Toxicity: | 0.393 |
Rat Oral Acute Toxicity: | 0.858 | Maximum Recommended Daily Dose: | 0.951 |
Skin Sensitization: | 0.941 | Carcinogencity: | 0.967 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.028 |
Respiratory Toxicity: | 0.984 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003709 | 0.727 | D0FG6M | 0.214 | ||||
ENC003762 | 0.670 | D0H2MO | 0.186 | ||||
ENC005987 | 0.655 | D0MY8N | 0.184 | ||||
ENC003500 | 0.516 | D00DKK | 0.183 | ||||
ENC003887 | 0.504 | D0G3PI | 0.183 | ||||
ENC003128 | 0.492 | D02DGU | 0.183 | ||||
ENC005695 | 0.448 | D0E9KA | 0.179 | ||||
ENC003250 | 0.447 | D05QDC | 0.176 | ||||
ENC003886 | 0.438 | D0KR9U | 0.171 | ||||
ENC002144 | 0.430 | D0S7WX | 0.168 |